专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP0867470A1 Inulin based hydrocolloid compositions 失效
标题翻译： Zusammensetzungen von Inulin und Hydrokolloiden
公开(公告)号：EP0867470A1
公开(公告)日：1998-09-30
申请号：EP97870039.1
申请日：1997-03-24
申请人： Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)
发明人： Frippiat, Anne
IPC分类号： C08L5/00 , A23L1/052
CPC分类号： C08L3/02 , A23L29/212 , A23L29/231 , A23L29/238 , A23L29/244 , A23L29/256 , A23L29/262 , A23L29/27 , A23L29/272 , A23L29/284 , A23L29/35 , A23L35/20 , C08L5/00 , C08L2666/02
摘要： The present invention concerns a synergistic composition of hydrocolloids comprising a combination of inulin and another hydrocolloid which is a gelling agent. Preferably the concentration ratio of the components is within the range at which the ratio of the gel strengths of the individual components varies from 0.05 to 20. The use of said composition to obtain a predetermined gel strength in a food product or in an ingredient thereof is also provided.
摘要翻译：本发明涉及包含菊糖和作为胶凝剂的另一种水解胶体的组合的水胶体的协同组合物。优选地，组分的浓度比在各个组分的凝胶强度的比率在0.05至20之间变化的范围内。所述组合物在食品或其成分中获得预定凝胶强度的用途是也提供。

2. 发明授权

EP0867470B1 Inulin based hydrocolloid compositions 失效
标题翻译：菊糖和胶体的组成
公开(公告)号：EP0867470B1
公开(公告)日：2003-05-28
申请号：EP97870039.1
申请日：1997-03-24
申请人： Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)
发明人： Frippiat, Anne
IPC分类号： C08L5/00 , A23L1/052
CPC分类号： C08L3/02 , A23L29/212 , A23L29/231 , A23L29/238 , A23L29/244 , A23L29/256 , A23L29/262 , A23L29/27 , A23L29/272 , A23L29/284 , A23L29/35 , A23L35/20 , C08L5/00 , C08L2666/02

3. 发明公开

EP0958825A1 Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer 失效
标题翻译：包括用于治疗癌症的协同增效组合物，其非消化性碳水化合物和抗癌剂的
公开(公告)号：EP0958825A1
公开(公告)日：1999-11-24
申请号：EP98870113.2
申请日：1998-05-18
申请人： Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)
发明人： Taper, Henryk , Frippiat, Anne , Van Loo, Jan , Roberfroid, Marcel
IPC分类号： A61K31/70 , A61K31/505 , A61K31/52 , A61K31/17
CPC分类号： A61K31/7004 , A61K31/715 , A61K45/06 , A61K31/70 , A61K31/52 , A61K31/505 , A61K31/17 , A61K2300/00
摘要： The present invention provides (i) a novel pharmaceutical composition comprising a synergistic combination of a non-digestible fructan-type carbohydrate, i.e. a levan or an inulin (including inulin, oligofructose and mixtures thereof) and an anti-metabolic anti-cancer drug, (ii) said composition for use in the treatment of cancer in non-ruminating mammals, (iii) the use of said combination for the manufacture of a medicament for the treatment of cancer in non-ruminating mammals, and (iv) the use of said composition in a method for treatment of cancer in non-ruminating mammals.
摘要翻译：本发明提供了（ⅰ）的新的药物组合物，包含不易消化的果聚糖型糖的协同组合，即一万特或菊糖（包括菊糖，寡果糖和它们的混合物）和抗代谢抗癌药的，（ii）所述在非反刍哺乳动物中治疗癌症的组合物，（iii）使用所述组合的用于制备药物用于非反刍哺乳动物治疗癌症，以及（iv）使用所述组合物的方法中的用于在非反刍哺乳动物治疗癌症。

4. 发明公开

EP0879600A1 Fructan containing composition for the prevention and treatment of colon cancer 失效
标题翻译： Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
公开(公告)号：EP0879600A1
公开(公告)日：1998-11-25
申请号：EP97870069.8
申请日：1997-05-20
申请人： Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)
发明人： Van Loo, Jan , Frippiat, Anne
IPC分类号： A61K31/715
CPC分类号： A61K31/733 , A23L29/055 , A23L29/244
摘要： The use is provided of a fructran with an average degree of polymerisation of at least 15 for the manufacture of a composition for the prevention and/or treatment of colon cancer in non-bovine mammals, particularly in human beings.
Also provided is a method of prevention and treatment of colon cancer in a non-bovine mammal, particularly in a human being, comprising administering to said mammal a composition comprising an effective dose of a fructan with an average degree of polymerisation of at least 15.
The said composition can be a medicament as well as a functional food. In a preferrred embodiment the fructan is inulin, more preferably inulin with an average degree of polymerisation of at least 20.
摘要翻译：使用平均聚合度至少为15的果聚糖，用于制造用于预防和/或治疗非牛哺乳动物，特别是人类中的结肠癌的组合物。还提供了预防和治疗非牛哺乳动物，特别是人的结肠癌的方法，包括向所述哺乳动物施用包含平均聚合度至少为15的有效剂量的果聚糖的组合物。所述组合物可以是药物以及功能性食品。在优选的实施方案中，果聚糖是菊粉，更优选菊糖，平均聚合度至少为20。

5. 发明公开

EP1125507A1 Inulin products with improved nutritional properties 审中-公开
标题翻译：菊苣生产者动物点心（Nahrungseigenschaften）
公开(公告)号：EP1125507A1
公开(公告)日：2001-08-22
申请号：EP00103056.8
申请日：2000-02-15
申请人： Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)
发明人： Frippiat, Anne , Van Loo, Jan , Smits, Georges
IPC分类号： A23L1/0528
CPC分类号： A61K31/733 , A23L29/244
摘要： The invention relates to novel inulin products and compositions thereof, to their manufacture and to their use for modulating the bacterial flora and the fermentation pattern of inulin in the large intestine of humans and mammals, to their use for providing improved inulin-associated nutritional effects/benefits, and to their use for the manufacture of a pharmaceutical composition for providing said effects/benefits in humans and mammals.
The novel inulin products consist of a mixture of an easily fermentable inulin (EFI) component (preferably an oligofructose, an agave inulin, or a mixture thereof) and a hardly fermentable inulin (HFI) component (preferably a long-chain inulin with a ( DP ¯ ) ≥ 20, typically chicory inulin with a ( DP ¯ ) ≥ 23), in a weight ratio ranging from 10/90 to 70/30.
The nutritional effects include improved mineral absorption, particularly calcium and magnesium, bone mineral density increase, reduction of bone mineral density loss, improvement of bone structure, modulation of lipid metabolism, stimulation of the immune system, and anti-cancer effects. The novel inulin products are particularly suitable for the manufacture of a composition or a medicament for preventing, for postponing and for treating osteoporosis in humans, particularly postmenopausal women.
摘要翻译：本发明涉及新颖的菊粉产品及其组合物，其制备及其用于调节人类和哺乳动物大肠中菊糖的细菌菌群和发酵模式的用途，用于提供改善的菊粉相关营养效应/ 益处以及用于制造用于在人类和哺乳动物中提供所述效果/益处的药物组合物的用途。新颖的菊粉产品由容易发酵的菊粉（EFI）组分（优选低聚果糖，龙舌兰菊糖或其混合物）和几乎可发酵的菊粉（HFI）组分（优选长链菊粉与（ DP）≥20，通常为（DP）≥23的菊苣菊糖），重量比为10/90至70/30。营养作用包括改善矿物质吸收，特别是钙和镁，骨矿物质密度增加，骨矿物质密度损失减少，骨结构改善，脂质代谢调节，免疫系统刺激和抗癌作用。新颖的菊粉产品特别适用于制造用于预防，延缓和治疗人类，特别是绝经后妇女的骨质疏松症的组合物或药物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式